Literature DB >> 26555637

CCN4/WISP-1 positively regulates chondrogenesis by controlling TGF-β3 function.

Yuya Yoshioka1, Mitsuaki Ono2, Azusa Maeda3, Tina M Kilts4, Emilio Satoshi Hara5, Hany Khattab6, Junji Ueda1, Eriko Aoyama7, Toshitaka Oohashi7, Masaharu Takigawa7, Marian F Young4, Takuo Kuboki1.   

Abstract

The CCN family of proteins plays important roles in development and homeostasis of bone and cartilage. To understand the role of CCN4 in chondrogenesis, human bone marrow stromal cells (hBMSCs) were transduced with CCN4 adenovirus (adCCN4) or siRNA to CCN4 (siCCN4) in the presence or absence of transforming growth factor-β3 (TGF-β3). Overexpression of CCN4 enhanced TGF-β3-induced SMAD2/3 phosphorylation and chondrogenesis of hBMSCs in an in vitro assay using a micromass culture model. On the other hand, knockdown of CCN4 inhibited the TGF-β3-induced SMAD2/3 phosphorylation and synthesis of cartilage matrix in micromass cultures of hBMSCs. Immunoprecipitation-western blot analysis revealed that CCN4 bound to TGF-β3 and regulated the ability of TGF-β3 to bind to hBMSCs. In vivo analysis confirmed there was a significant decrease in the gene expression levels of chondrocyte markers in cartilage samples from Ccn4-knock out (KO) mice, compared to those from wild type (WT) control. In order to investigate the regenerative properties of the articular cartilage in Ccn4-KO mice, articular cartilage defects were surgically performed in the knee joints of young mice, and the results showed that the cartilage was partially repaired in WT mice, but not in Ccn4-KO mice. In conclusion, these results show, for the first time, that CCN4 has a positive influence on chondrogenic differentiation by modulating the effects of TGF-β3.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Articular cartilage; Bone marrow stromal cell (BMSC); CCN4/WISP-1; Chondrogenesis; TGF-β3

Mesh:

Substances:

Year:  2015        PMID: 26555637      PMCID: PMC5749225          DOI: 10.1016/j.bone.2015.11.007

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  29 in total

1.  Tumor necrosis factor alpha can contribute to focal loss of cartilage in osteoarthritis.

Authors:  C I Westacott; A F Barakat; L Wood; M J Perry; P Neison; I Bisbinas; L Armstrong; A B Millar; C J Elson
Journal:  Osteoarthritis Cartilage       Date:  2000-05       Impact factor: 6.576

2.  CCN2/CTGF binds to fibroblast growth factor receptor 2 and modulates its signaling.

Authors:  Eriko Aoyama; Satoshi Kubota; Masaharu Takigawa
Journal:  FEBS Lett       Date:  2012-11-06       Impact factor: 4.124

3.  WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene.

Authors:  L Xu; R B Corcoran; J W Welsh; D Pennica; A J Levine
Journal:  Genes Dev       Date:  2000-03-01       Impact factor: 11.361

4.  Expression and physiological role of CCN4/Wnt-induced secreted protein 1 mRNA splicing variants in chondrocytes.

Authors:  Takeshi Yanagita; Satoshi Kubota; Harumi Kawaki; Kazumi Kawata; Seiji Kondo; Teruko Takano-Yamamoto; Shinji Tanaka; Masaharu Takigawa
Journal:  FEBS J       Date:  2007-04       Impact factor: 5.542

5.  N-terminal domains of CCN family 2/connective tissue growth factor bind to aggrecan.

Authors:  Eriko Aoyama; Takako Hattori; Mitsuhiro Hoshijima; Daisuke Araki; Takashi Nishida; Satoshi Kubota; Masaharu Takigawa
Journal:  Biochem J       Date:  2009-05-27       Impact factor: 3.857

6.  Transforming growth factor-beta1 gene polymorphisms and bone turnover, bone mineral density and fracture risk in southern Chinese women.

Authors:  H H L Lau; A Y Y Ho; K D K Luk; A W C Kung
Journal:  Calcif Tissue Int       Date:  2004-06       Impact factor: 4.333

7.  Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta.

Authors:  José G Abreu; Nan I Ketpura; Bruno Reversade; E M De Robertis
Journal:  Nat Cell Biol       Date:  2002-08       Impact factor: 28.824

8.  Regeneration of defects in articular cartilage in rat knee joints by CCN2 (connective tissue growth factor).

Authors:  Takashi Nishida; Satoshi Kubota; Shunji Kojima; Takuo Kuboki; Kyouji Nakao; Toshihiro Kushibiki; Yasuhiko Tabata; Masaharu Takigawa
Journal:  J Bone Miner Res       Date:  2004-03-29       Impact factor: 6.741

9.  CCN family member 2/connective tissue growth factor (CCN2/CTGF) has anti-aging effects that protect articular cartilage from age-related degenerative changes.

Authors:  Shinsuke Itoh; Takako Hattori; Nao Tomita; Eriko Aoyama; Yasutaka Yutani; Takashi Yamashiro; Masaharu Takigawa
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

10.  Association of a single nucleotide polymorphism in the WISP1 gene with spinal osteoarthritis in postmenopausal Japanese women.

Authors:  Tomohiko Urano; Ken'ichiro Narusawa; Masataka Shiraki; Takahiko Usui; Noriko Sasaki; Takayuki Hosoi; Yasuyoshi Ouchi; Toshitaka Nakamura; Satoshi Inoue
Journal:  J Bone Miner Metab       Date:  2007-06-25       Impact factor: 2.976

View more
  9 in total

1.  WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial-mesenchymal transition.

Authors:  Wentao Deng; Audry Fernandez; Sarah L McLaughlin; David J Klinke
Journal:  J Biol Chem       Date:  2019-02-05       Impact factor: 5.157

2.  WISP1 is associated to advanced disease, EMT and an inflamed tumor microenvironment in multiple solid tumors.

Authors:  Pierre-Olivier Gaudreau; Sylvie Clairefond; Caleb A Class; Pierre-Luc Boulay; Pavel Chrobak; Bertrand Allard; Feryel Azzi; Sandra Pommey; Kim-Anh Do; Fred Saad; Dominique Trudel; Marian Young; John Stagg
Journal:  Oncoimmunology       Date:  2019-03-22       Impact factor: 8.110

Review 3.  The role of CCNs in controlling cellular communication in the tumor microenvironment.

Authors:  Lauren B Birkeness; Snigdha Banerjee; Mohiuddin Quadir; Sushanta K Banerjee
Journal:  J Cell Commun Signal       Date:  2022-06-08       Impact factor: 5.908

4.  Aging Disrupts Muscle Stem Cell Function by Impairing Matricellular WISP1 Secretion from Fibro-Adipogenic Progenitors.

Authors:  Laura Lukjanenko; Sonia Karaz; Pascal Stuelsatz; Uxia Gurriaran-Rodriguez; Joris Michaud; Gabriele Dammone; Federico Sizzano; Omid Mashinchian; Sara Ancel; Eugenia Migliavacca; Sophie Liot; Guillaume Jacot; Sylviane Metairon; Frederic Raymond; Patrick Descombes; Alessio Palini; Benedicte Chazaud; Michael A Rudnicki; C Florian Bentzinger; Jerome N Feige
Journal:  Cell Stem Cell       Date:  2019-01-24       Impact factor: 24.633

5.  Endogenous CCN family member WISP1 inhibits trauma-induced heterotopic ossification.

Authors:  Ginny Ching-Yun Hsu; Simone Marini; Stefano Negri; Yiyun Wang; Jiajia Xu; Chase Pagani; Charles Hwang; David Stepien; Carolyn A Meyers; Sarah Miller; Edward McCarthy; Karen M Lyons; Benjamin Levi; Aaron W James
Journal:  JCI Insight       Date:  2020-07-09

6.  CCN4/WISP1 controls cutaneous wound healing by modulating proliferation, migration and ECM expression in dermal fibroblasts via α5β1 and TNFα.

Authors:  Mitsuaki Ono; Asuka Masaki; Azusa Maeda; Tina M Kilts; Emilio S Hara; Taishi Komori; Hai Pham; Takuo Kuboki; Marian F Young
Journal:  Matrix Biol       Date:  2018-01-10       Impact factor: 11.583

7.  Post-traumatic osteoarthritis development is not modified by postnatal chondrocyte deletion of Ccn2.

Authors:  Craig M Keenan; Lorenzo Ramos-Mucci; Ioannis Kanakis; Peter I Milner; Andrew Leask; David Abraham; George Bou-Gharios; Blandine Poulet
Journal:  Dis Model Mech       Date:  2020-07-14       Impact factor: 5.758

Review 8.  Cellular communication network factor 3 in cartilage development and maintenance.

Authors:  Satoshi Kubota; Harumi Kawaki; Bernard Perbal; Kazumi Kawata; Takako Hattori; Takashi Nishida
Journal:  J Cell Commun Signal       Date:  2021-06-14       Impact factor: 5.782

Review 9.  CCN proteins in the musculoskeletal system: current understanding and challenges in physiology and pathology.

Authors:  Veronica Giusti; Katia Scotlandi
Journal:  J Cell Commun Signal       Date:  2021-07-06       Impact factor: 5.782

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.